CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Cabazitaxel vs docetaxel in chemotherapy-naive (CN) patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm phase III study (FIRSTANA).
Author
A. Oliver Sartor
Antoine Thiery-Vuillemin
+14Â more
Daniel E. Castellano
Fred Saad
Gedske Daugaard
Jacek Jassem
John P Bernard
Karim Fizazi
Liji Shen
Lisa Sengelov
Marie Hjelm-Eriksson
Mustapha Chadjaa
Orazio Caffo
Paul N. Mainwaring
Steinbjoern Hansen
Stephane Oudard
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref